S&P 500   3,386.15 (+0.47%)
DOW   29,348.03 (+0.40%)
QQQ   236.98 (+0.96%)
AAPL   323.62 (+1.45%)
FB   217.49 (-0.14%)
MSFT   187.28 (+0.03%)
GOOGL   1,524.87 (+0.36%)
AMZN   2,170.22 (+0.67%)
CGC   21.77 (-0.77%)
NVDA   314.70 (+6.11%)
MU   59.99 (+3.88%)
GE   12.61 (-1.10%)
TSLA   917.42 (+6.88%)
AMD   58.90 (+3.53%)
NFLX   386.19 (-0.41%)
DIS   141.30 (+1.55%)
GILD   67.35 (+0.51%)
S&P 500   3,386.15 (+0.47%)
DOW   29,348.03 (+0.40%)
QQQ   236.98 (+0.96%)
AAPL   323.62 (+1.45%)
FB   217.49 (-0.14%)
MSFT   187.28 (+0.03%)
GOOGL   1,524.87 (+0.36%)
AMZN   2,170.22 (+0.67%)
CGC   21.77 (-0.77%)
NVDA   314.70 (+6.11%)
MU   59.99 (+3.88%)
GE   12.61 (-1.10%)
TSLA   917.42 (+6.88%)
AMD   58.90 (+3.53%)
NFLX   386.19 (-0.41%)
DIS   141.30 (+1.55%)
GILD   67.35 (+0.51%)
S&P 500   3,386.15 (+0.47%)
DOW   29,348.03 (+0.40%)
QQQ   236.98 (+0.96%)
AAPL   323.62 (+1.45%)
FB   217.49 (-0.14%)
MSFT   187.28 (+0.03%)
GOOGL   1,524.87 (+0.36%)
AMZN   2,170.22 (+0.67%)
CGC   21.77 (-0.77%)
NVDA   314.70 (+6.11%)
MU   59.99 (+3.88%)
GE   12.61 (-1.10%)
TSLA   917.42 (+6.88%)
AMD   58.90 (+3.53%)
NFLX   386.19 (-0.41%)
DIS   141.30 (+1.55%)
GILD   67.35 (+0.51%)
S&P 500   3,386.15 (+0.47%)
DOW   29,348.03 (+0.40%)
QQQ   236.98 (+0.96%)
AAPL   323.62 (+1.45%)
FB   217.49 (-0.14%)
MSFT   187.28 (+0.03%)
GOOGL   1,524.87 (+0.36%)
AMZN   2,170.22 (+0.67%)
CGC   21.77 (-0.77%)
NVDA   314.70 (+6.11%)
MU   59.99 (+3.88%)
GE   12.61 (-1.10%)
TSLA   917.42 (+6.88%)
AMD   58.90 (+3.53%)
NFLX   386.19 (-0.41%)
DIS   141.30 (+1.55%)
GILD   67.35 (+0.51%)
Log in

Tonix Pharmaceuticals News Headlines (NASDAQ:TNXP)

$0.42
-0.01 (-2.33 %)
(As of 02/19/2020 04:00 PM ET)
Today's Range
$0.41
Now: $0.42
$0.43
50-Day Range
$0.43
MA: $1.22
$1.70
52-Week Range
$0.41
Now: $0.42
$42.00
Volume34,636 shs
Average Volume2.42 million shs
Market Capitalization$3.57 million
P/E RatioN/A
Dividend YieldN/A
Beta1.08

Headlines

Tonix Pharmaceuticals (NASDAQ TNXP) News Headlines

Source:
DateHeadline
Zacks: Brokerages Expect Tonix Pharmaceuticals Holding Corp (NASDAQ:TNXP) Will Announce Earnings of -$1.49 Per ShareZacks: Brokerages Expect Tonix Pharmaceuticals Holding Corp (NASDAQ:TNXP) Will Announce Earnings of -$1.49 Per Share
www.americanbankingnews.com - February 14 at 11:13 AM
Tonix Pharmaceuticals Holding Corp (NASDAQ:TNXP) Sees Large Increase in Short InterestTonix Pharmaceuticals Holding Corp (NASDAQ:TNXP) Sees Large Increase in Short Interest
www.americanbankingnews.com - February 11 at 6:26 PM
Tonix Pharmaceuticals Prices $7.5 million Public OfferingTonix Pharmaceuticals Prices $7.5 million Public Offering
finance.yahoo.com - February 7 at 9:07 AM
BTAI Hits A High, TNXPs RECOVERY Fails, MRK Plans A Spin-offBTAI Hits A High, TNXP's RECOVERY Fails, MRK Plans A Spin-off
www.nasdaq.com - February 6 at 8:14 AM
Tonix Pharmaceuticals down 60% premarket on failed Tonmya studyTonix Pharmaceuticals down 60% premarket on failed Tonmya study
seekingalpha.com - February 6 at 8:14 AM
Tonix Pharmaceuticals Announces Outcome of Interim Analysis for Phase 3 RECOVERY Study of Tonmya® (TNX-102 SL) in PTSDTonix Pharmaceuticals Announces Outcome of Interim Analysis for Phase 3 RECOVERY Study of Tonmya® (TNX-102 SL) in PTSD
finance.yahoo.com - February 5 at 7:10 PM
Tonix Pharmaceuticals to Participate in Upcoming February Investor ConferencesTonix Pharmaceuticals to Participate in Upcoming February Investor Conferences
finance.yahoo.com - February 4 at 8:49 AM
Financial Contrast: Acerus Pharmaceuticals (OTCMKTS:TRLPF) versus Tonix Pharmaceuticals (OTCMKTS:TNXP)Financial Contrast: Acerus Pharmaceuticals (OTCMKTS:TRLPF) versus Tonix Pharmaceuticals (OTCMKTS:TNXP)
www.americanbankingnews.com - February 2 at 10:42 PM
Tonix Pharmaceuticals Moves Ahead, And Other News: The Good, Bad, And Ugly Of BiopharmaTonix Pharmaceuticals Moves Ahead, And Other News: The Good, Bad, And Ugly Of Biopharma
seekingalpha.com - January 30 at 6:46 PM
Does The Tonix Pharmaceuticals Holding Corp. (NASDAQ:TNXP) Share Price Tend To Follow The Market?Does The Tonix Pharmaceuticals Holding Corp. (NASDAQ:TNXP) Share Price Tend To Follow The Market?
finance.yahoo.com - January 29 at 6:26 PM
Tonix Pharmaceuticals Presented Results from a Preclinical Study of TNX-801, a Potential Vaccine to Prevent Smallpox and Monkeypox, in a Poster Presentation at the 2020 American Society for Microbiology (ASM) Biothreats ConferenceTonix Pharmaceuticals Presented Results from a Preclinical Study of TNX-801, a Potential Vaccine to Prevent Smallpox and Monkeypox, in a Poster Presentation at the 2020 American Society for Microbiology (ASM) Biothreats Conference
finance.yahoo.com - January 29 at 6:26 PM
Company News for Jan 27, 2020Company News for Jan 27, 2020
finance.yahoo.com - January 27 at 12:44 PM
Short Interest in Tonix Pharmaceuticals Holding Corp (NASDAQ:TNXP) Decreases By 66.6%Short Interest in Tonix Pharmaceuticals Holding Corp (NASDAQ:TNXP) Decreases By 66.6%
www.americanbankingnews.com - January 26 at 8:44 PM
6 Healthcare Stocks Moving In Fridays Pre-Market Session6 Healthcare Stocks Moving In Friday's Pre-Market Session
www.benzinga.com - January 24 at 9:00 AM
4 Biotechnology Stocks Moving In Fridays Pre-Market Session4 Biotechnology Stocks Moving In Friday's Pre-Market Session
www.benzinga.com - January 24 at 9:00 AM
Tonix Pharma up 42% premarket on advancement of TNX-102 SLTonix Pharma up 42% premarket on advancement of TNX-102 SL
seekingalpha.com - January 24 at 9:00 AM
Tonix Pharmaceuticals Announces Successful Completion of a Fed-Fasting and Dose Proportionality Study of TNX-102 SLTonix Pharmaceuticals Announces Successful Completion of a Fed-Fasting and Dose Proportionality Study of TNX-102 SL
finance.yahoo.com - January 24 at 9:00 AM
Tonix Pharmaceuticals to Present Results from Preclinical Study of TNX-801 in a Poster Presentation at the 2020 American Society for Microbiology (ASM) Biothreats ConferenceTonix Pharmaceuticals to Present Results from Preclinical Study of TNX-801 in a Poster Presentation at the 2020 American Society for Microbiology (ASM) Biothreats Conference
finance.yahoo.com - January 23 at 12:59 PM
Tonix Pharma files for equity offering; shares down 9% premarketTonix Pharma files for equity offering; shares down 9% premarket
seekingalpha.com - January 21 at 7:59 AM
Tonix Pharmaceuticals Holding (TNXP) Presents At Biotech Showcase 2020 - SlideshowTonix Pharmaceuticals Holding (TNXP) Presents At Biotech Showcase 2020 - Slideshow
seekingalpha.com - January 14 at 3:49 PM
Thinking about buying stock in Canopy Growth Corp, FuelCell Energy, LYFT, Square, or Tonix Pharmaceuticals?Thinking about buying stock in Canopy Growth Corp, FuelCell Energy, LYFT, Square, or Tonix Pharmaceuticals?
www.marketwatch.com - January 7 at 4:06 PM
Tonix Pharmaceuticals to Present at Biotech Showcase 2020Tonix Pharmaceuticals to Present at Biotech Showcase 2020
finance.yahoo.com - January 7 at 4:06 PM
Tonix Pharma up 10% on development plan for once-daily MDD pillTonix Pharma up 10% on development plan for once-daily MDD pill
seekingalpha.com - December 16 at 5:37 PM
Tonix Pharmaceuticals Announces Plan to Develop TNX-601 CR Tablets for Once-Daily Treatment of Major Depressive Disorder, in Addition to PTSD, After Successful Completion of Phase 1 Pharmacokinetic StudyTonix Pharmaceuticals Announces Plan to Develop TNX-601 CR Tablets for Once-Daily Treatment of Major Depressive Disorder, in Addition to PTSD, After Successful Completion of Phase 1 Pharmacokinetic Study
finance.yahoo.com - December 16 at 5:37 PM
TNXP: TNX-102 SL P3 PTSD Trial Interim Readout in 1Q20; P3 Trial in Fibromyalgia Underway…TNXP: TNX-102 SL P3 PTSD Trial Interim Readout in 1Q20; P3 Trial in Fibromyalgia Underway…
finance.yahoo.com - December 16 at 12:36 PM
Tonix Vaults on European PatentTonix Vaults on European Patent
www.baystreet.ca - December 12 at 2:21 PM
Tonix Pharma nabs European patent covering TNX-102 SL; shares up 22% AHTonix Pharma nabs European patent covering TNX-102 SL; shares up 22% AH
seekingalpha.com - December 11 at 5:28 PM
Tonix Pharmaceuticals Announces New European Patent for the Composition and Formulation of TNX-102 SLTonix Pharmaceuticals Announces New European Patent for the Composition and Formulation of TNX-102 SL
finance.yahoo.com - December 11 at 5:28 PM
Tonix Pharma begins patient enrollment in late-stage RELIEF study for fibromyalgiaTonix Pharma begins patient enrollment in late-stage RELIEF study for fibromyalgia
seekingalpha.com - December 10 at 12:56 PM
Tonix Pharmaceuticals Enrolls First Patient in Phase 3 RELIEF Study of TNX-102 SL for the Management of FibromyalgiaTonix Pharmaceuticals Enrolls First Patient in Phase 3 RELIEF Study of TNX-102 SL for the Management of Fibromyalgia
finance.yahoo.com - December 10 at 7:55 AM
Tonix Pharmaceuticals to Present at 12th Annual LD Micro Main EventTonix Pharmaceuticals to Present at 12th Annual LD Micro Main Event
finance.yahoo.com - December 4 at 8:38 AM
Tonix Pharmaceuticals Announces Receipt of FDA Official Minutes from Breakthrough Therapy Type B Clinical Guidance Meeting for Tonmya® as a Potential New Treatment for PTSDTonix Pharmaceuticals Announces Receipt of FDA Official Minutes from Breakthrough Therapy Type B Clinical Guidance Meeting for Tonmya® as a Potential New Treatment for PTSD
finance.yahoo.com - November 26 at 8:30 PM
Tonix Pharmaceuticals to Participate in Benchmark’s Annual Discovery 1x1 ConferenceTonix Pharmaceuticals to Participate in Benchmark’s Annual Discovery 1x1 Conference
finance.yahoo.com - November 25 at 7:59 PM
Tonix Pharmaceuticals Announces Initiation of the Phase 3 RELIEF Study of TNX-102 SL for the Management of FibromyalgiaTonix Pharmaceuticals Announces Initiation of the Phase 3 RELIEF Study of TNX-102 SL for the Management of Fibromyalgia
finance.yahoo.com - November 21 at 12:58 PM
Tonix Plans Regulatory Filing To Kick Off Study Of Alcohol Use Disorder DrugTonix Plans Regulatory Filing To Kick Off Study Of Alcohol Use Disorder Drug
finance.yahoo.com - November 21 at 12:58 PM
Tonix Pharma up 12% after hours on advancement of TNX-102 SL in AUDTonix Pharma up 12% after hours on advancement of TNX-102 SL in AUD
seekingalpha.com - November 20 at 7:31 PM
Tonix Pharmaceuticals Completes Pre-IND Meeting with FDA for TNX-102 SL as a Clinical Candidate for Alcohol Use DisorderTonix Pharmaceuticals Completes Pre-IND Meeting with FDA for TNX-102 SL as a Clinical Candidate for Alcohol Use Disorder
finance.yahoo.com - November 20 at 7:31 PM
Tonix Pharmaceuticals Announces Closing of $9.0 Million Public OfferingTonix Pharmaceuticals Announces Closing of $9.0 Million Public Offering
finance.yahoo.com - November 20 at 7:44 AM
Tonix Pharmaceuticals Prices $9.0 Million Public OfferingTonix Pharmaceuticals Prices $9.0 Million Public Offering
finance.yahoo.com - November 15 at 9:07 AM
Tonix Pharmaceuticals Reports Third Quarter 2019 Financial Results and Operational HighlightsTonix Pharmaceuticals Reports Third Quarter 2019 Financial Results and Operational Highlights
finance.yahoo.com - November 8 at 7:29 PM
Tonix Pharmaceuticals Announces 12-Week Primary Endpoint and Addition of Adaptive Design Features in the Currently-Enrolling Phase 3 RECOVERY Study of Tonmya® for PTSD, Following FDA MeetingTonix Pharmaceuticals Announces 12-Week Primary Endpoint and Addition of Adaptive Design Features in the Currently-Enrolling Phase 3 RECOVERY Study of Tonmya® for PTSD, Following FDA Meeting
finance.yahoo.com - November 4 at 9:04 AM
Tonix Pharma up 24% after reverse splitTonix Pharma up 24% after reverse split
seekingalpha.com - November 1 at 11:20 PM
Companies Like Tonix Pharmaceuticals Holding (NASDAQ:TNXP) Can Be Considered Quite RiskyCompanies Like Tonix Pharmaceuticals Holding (NASDAQ:TNXP) Can Be Considered Quite Risky
finance.yahoo.com - October 30 at 6:17 PM
Tonix Pharmaceuticals Holding (TNXP) Investor Presentation - SlideshowTonix Pharmaceuticals Holding (TNXP) Investor Presentation - Slideshow
seekingalpha.com - October 29 at 8:58 AM
Tonix Pharmaceuticals Announces Issuance of U.S. Patent for Crystalline Tianeptine Oxalate Salt, the Active Ingredient of TNX-601Tonix Pharmaceuticals Announces Issuance of U.S. Patent for Crystalline Tianeptine Oxalate Salt, the Active Ingredient of TNX-601
finance.yahoo.com - October 23 at 8:00 AM
Tonix Pharma files to offer 16.7M sharesTonix Pharma files to offer 16.7M shares
seekingalpha.com - October 18 at 11:26 PM
BRIEF-Tonix Pharmaceuticals Holding Files For Offering 16.7 Mln Shares Of Common StockBRIEF-Tonix Pharmaceuticals Holding Files For Offering 16.7 Mln Shares Of Common Stock
www.msn.com - October 18 at 6:26 PM
Tonix Pharmaceuticals Joins the Alliance for BiosecurityTonix Pharmaceuticals Joins the Alliance for Biosecurity
finance.yahoo.com - October 15 at 8:43 AM
Tonix Pharmaceuticals Announces that the European Patent Office Opposition Division Has Upheld Its Patent for the Use of the Active Ingredient in TNX-102 SL, Cyclobenzaprine, for the Treatment of PTSDTonix Pharmaceuticals Announces that the European Patent Office Opposition Division Has Upheld Its Patent for the Use of the Active Ingredient in TNX-102 SL, Cyclobenzaprine, for the Treatment of PTSD
finance.yahoo.com - October 7 at 8:04 AM
Tonix Pharmaceuticals Announces Completion of Long-Term Exposure Studies in Participants with PTSD to Evaluate the Tolerability of TNX-102 SL 5.6 mgTonix Pharmaceuticals Announces Completion of Long-Term Exposure Studies in Participants with PTSD to Evaluate the Tolerability of TNX-102 SL 5.6 mg
finance.yahoo.com - October 3 at 9:18 AM
This page was last updated on 2/19/2020 by MarketBeat.com Staff

Featured Article: Buy Rating

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.

Yahoo Gemini Pixel